ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Levin Leaves UCSF for M.D. Anderson; Copeland Moves to Ohio State; OC’s Alice Hamm Retires

July 1, 1988

Lung, Head & Neck Treatment Advances Reported At ASCO Annual Meeting

May 27, 1977

No Link Between Pneumonitis, Taxanes, And Radiation

November 26, 2004

PDQ Now Offers CME Credit to Physician Users

July 3, 1987

Research vs. Delivery? Advisors Debate NCI Role In Review of Community Program.

November 21, 2008

Ibrutinib Shows Disease Control In Elderly, High-Risk CLL Patients

April 26, 2013